Pall appoints two corporate vice presidents

Glen Petaja, president of its Global Advanced Separation Systems, and Jeff Seibert, president of its fast-growing Water Processing Business, are named as corporate vice presidents of the high-purity filtration specialist...

EAST HILLS, NY, Nov. 10, 2005 -- Pall Corp. today named Glen Petaja a corporate vice president with global responsibility for the Pall Advanced Separation Systems (PASS) business. It also announced the promotion of Jeff Seibert to corporate vice president as well with responsibility for Pall's rapidly growing Water Processing business.

Advanced Separation
Petaja has served as president of PASS since its inception in 2002 and will retain that title. He's based in Cortland, N.Y. Systems, which grew over 27% last year, are one of the fastest growing areas for Pall and currently account for about 10% of total worldwide sales.

The PASS division's scope recently was expanded by adding fabrication to its responsibilities for design, procurement and service of all Pall system platforms. By integrating fabrication with engineering, the company anticipates even greater efficiency and cost effectiveness.

For the full release of this Advanced Separation announcement, click here.

Water Processing
Seibert will continue to serve as president of the global Municipal Water business, which is on pace to post another record-setting year. Water processing is the fastest growing business within the company and grew by over 26% this past fiscal year.

He also assumes responsibility for the Industrial Water specialist team and development of the large global desalination market. In addition, he will spearhead Pall's new consumer/commercial water initiative.

For the full release of this Water Processing announcement, click here.

Both men are based in Cortland, N.Y.

Pall ( is a global leader in the rapidly growing field of filtration, separations and purification. Its business is organized around two broad markets: Life Sciences and Industrial. The company provides leading-edge products to meet the demanding needs of customers in biotechnology, pharmaceuticals, transfusion medicines, semiconductors, water purification, aerospace and broad industrial markets. Total revenue for fiscal 2005 were $1.9 billion. The headquarters are in East Hills, N.Y., with extensive operations throughout the world.


More in Treatment